Abstract
5-Flurouracil is a first-line agent in several cancer-therapy regimens. Cardiotoxicity is common, with coronary artery disease being an important risk factor. We report the case of an acute coronary syndrome presumably induced by 5-FU, in a patient with previously unknown and asymptomatic coronary artery disease, with and estimated intermediate risk for cardiovascular events. Pre-chemotherapy risk evaluation and optimal patient care are still not standardized in this clinical scenario.
| Original language | English |
|---|---|
| Article number | 791 |
| Journal | Revista Portuguesa de Cardiologia |
| Volume | 37 |
| Issue number | 9 |
| Early online date | 23 May 2018 |
| DOIs | |
| Publication status | Published - Sept 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- 5‐FU
- Angina Pectoris
- Angina pectoris
- Cardiotoxicidade
- Cardiotoxicity
Fingerprint
Dive into the research topics of 'Acute coronary syndrome in the oncology patient: An unpredictable event?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver